Biostax Corp Announces the FDAs Acceptance of Three Investigational New Drug Applications (IND) Transfers for JKB-122 for the Treatment of NASH, NAFLD and AIH

8M ago

IMUN

PremiumPress Releases

Biostax Corp. and Statera Biopharma, Inc. reach mutually beneficial dispute settlement and amended license agreement providing clearer clinical and commercial pathways for both companies

1y ago

IMUN

PremiumPress Releases

Immune Therapeutics, Inc. Announces Shareholder Approval of Name Change to Biostax Corp. and Unveils New Website, Business Strategies and Direction

1y ago

IMUN

PremiumPress Releases

Immune Therapeutics, Inc. Announces Management Change; Moves Forward with Repositioning Strategy and Long-acting TLR4 (Toll Like Receptor 4) Antagonist JKB-122 Development

1y ago

IMUN

PremiumPress Releases

Immune Therapeutics Appoints H. Louis Salomonksy to its Board of Directors

2y ago

IMUN

More IMUN News >

IMUN News on the Web

2023-09-14

Biostax Corp Announces the Passing of Esteemed Director, H. Louis Salomonsky

Yahoo Finance

Bullish

2023-08-29

Biostax Corp. Signs Collaboration Agreement with Immgenuity, Inc. to Pursue Remission in HIV

Yahoo Finance

Neutral

2023-08-15

Biostax Corp Announces the FDAs Acceptance of Three Investigational New Drug Applications Transfers for JKB-122 for the Treatment of NASH, NAFLD and AIH

Yahoo Finance

Neutral

2023-05-30

Biostax Launches Growth Funding Round to Revitalize Affordable Healthcare

Yahoo Finance

Neutral

2023-04-20

Biostax Corp. and Statera Biopharma, Inc. reach mutually beneficial dispute settlement and amended license agreement providing clearer clinical and commercial pathways for both companies

Yahoo Finance

Neutral

2023-03-01

Immune Therapeutics, Inc. Announces Shareholder Approval of Name Change to Biostax Corp. and Unveils New Website, Business Strategies and Direction

Yahoo Finance

Neutral

2022-11-09

Immune Therapeutics, Inc. Announces Management Change; Moves Forward with Repositioning Strategy and Long-acting TLR4 Antagonist JKB-122 Development

Yahoo Finance

Neutral

2022-04-28

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

InvestorPlace

Neutral

News Score - Last 7 Days

Not enough data to generate a sentiment score

Media Buzz

This Week0 articles

Weekly Average0 articles

News Sentiment

Currently, no data available

See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is IMUN’s Media Buzz Sentiment?

Currently, no data Available

What is IMUN’s weekly average amount of articles?

Currently, no data Available

What is IMUN’s News Sentiment?

Currently, no data Available

Healthcare Stocks that are Trending in the News

BMRNBioMarin Pharmaceutical

ACIUAC Immune SA

EUDAEUDA Health Holdings

SPROSpero Therapeutics

JAZZJazz Pharmaceuticals

Showing the stocks with the most bullish news sentiment over the past week

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing